Beaufond PLC continues to pursue its development strategy and once again delivers strong operating results, outperforming its industry. Beaufond PLC’s pharmaceutical business has recorded an excellent performance in 2020, exhibiting once again the relevance of its strategy and its
Recent Posts
- THE ILLUSION OF TRUCE: Decoding the U.S.–Iran War and the Myth of a Quick End
- The $1.1 Billion Paradox: Inside Emcure’s High-Stakes Legal Warfare, US FDA Scrutiny, and Leadership Exodus
- Why Healthcare in India Needs Urgent Attention?
- Beaufond PLC Eyes Dutch Pharma Alliance to Drive Oncology & Anti‑Malarial API Growth
- Trusted by His Tribe, Distrusted by the Nation: The Trump Paradox










